6955 — Shandong Boan Biotechnology Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$4.60bn
- HK$4.86bn
- CNY618.13m
Annual cashflow statement for Shandong Boan Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -241 | -225 | -332 | -119 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 10.6 | 28.8 | 23.6 | 36.4 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -293 | -99.7 | 33.4 | -18.3 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Net Change in Other Assets & Liabilities | ||||
| Cash from Operating Activities | -507 | -246 | -202 | -18.6 |
| Capital Expenditures | -131 | -341 | -206 | -295 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 112 | -91.1 | 106 | 1.19 |
| Change in Net Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -18.8 | -432 | -101 | -294 |
| Financing Cash Flow Items | 1,013 | 1,221 | -224 | 187 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 527 | 1,212 | -0.127 | 283 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 1.73 | 528 | -298 | -31.6 |